Page 4 - Briangm Durie News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Four Oral Presentations from the International Myeloma Foundation-Supported iStopMM Study to Take Center Stage at 2021 ASH Annual Meeting

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesGeorgia world congress centerSapna kumarSigurdury kristinssonSaemundur rognvaldssonDebra gendelSigrun thorsteinsdottirBriangm durieAmerican society of hematologyUniversity of icelandInternational myeloma working groupSwan research initiativeInternational myeloma foundationAmerican societyAnnual meetingIceland screens

The International Myeloma Foundation (IMF) Highlights Blood Cancer Awareness Month with the Do You Know Myeloma? Campaign

The International Myeloma Foundation (IMF) Highlights Blood Cancer Awareness Month with the Do You Know Myeloma? Campaign
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Daphne leeSapna kumarJen curranForrest shawAlie wardDebra gendelJoseph mikhaelBriangm durieInternational myeloma working groupSwan research initiativeInternational myeloma foundationBlood cancer awareness monthCancer awarenessBlack swan research initiativeDance theatreMom jen curran

The International Myeloma Foundation (IMF) Highlights Blood Cancer Awareness Month with the Do You Know Myeloma? Campaign

Bristol Myers Squibb Receives European Commission Approval for Abecma , the First Anti-BCMA CAR T Cell Therapy for Relapsed and Refractory Multiple Myeloma

Bristol Myers Squibb Receives European Commission Approval for Abecma , the First Anti-BCMA CAR T Cell Therapy for Relapsed and Refractory Multiple Myeloma
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.

United statesNew jerseyUnited kingdomGandhi ujjawalCornell robertHemophagocytic lymphohistiocytosisBristol myers squibbSamit hirawatLakshman arjunBriangm durieKimberly whitefieldAmerican society of clinical oncologyDrug administrationEuropean commissionBristol myers squibb companyExchange commission

International Myeloma Foundation Launches M-Power Charlotte to Improve Outcomes in Multiple Myeloma, a Cancer That Disproportionately Affects African Americans

Share this article LOS ANGELES, March 11, 2021 /PRNewswire/ The International Myeloma Foundation (IMF) today launched a multiyear , multidisciplinary initiative called M-Power Charlotte, designed to empower people to change the course of myeloma by removing barriers to early diagnosis and treatment in the African-American community. To that end, the IMF is working with Atrium Health Levine Cancer Institute s Disparities & Outreach program in Charlotte, NC, to enlist local leaders and healthcare professionals in promoting increased knowledge about this treatable but little-known disease. Launched by the International Myeloma Foundation, the M-Power Charlotte initiative is designed to empower people to change the course of myeloma by removing barriers to early diagnosis and treatment in the African-American community.

United statesSapna kumarDerek raghavanPeter voorheesDebra gendelManisha bhutaniJohn damontiJoseph mikhaelMellisa wheelerBriangm durieAtrium health levine cancer instituteInternational myeloma working groupBristol myers squibb foundationLevine cancer institute disparities outreachAtrium healthPlasma cell disorders division